CenterBook Partners LP Boosts Stock Position in Enovix Corporation $ENVX

CenterBook Partners LP raised its position in shares of Enovix Corporation (NASDAQ:ENVX) by 66.1% during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,757,382 shares of the company’s stock after purchasing an additional 699,519 shares during the quarter. CenterBook Partners LP owned 0.81% of Enovix worth $12,846,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. grew its stake in Enovix by 10.9% during the 4th quarter. Vanguard Group Inc. now owns 17,760,708 shares of the company’s stock valued at $129,831,000 after purchasing an additional 1,747,145 shares during the last quarter. Electron Capital Partners LLC grew its stake in Enovix by 13.8% during the 3rd quarter. Electron Capital Partners LLC now owns 8,038,396 shares of the company’s stock valued at $80,143,000 after purchasing an additional 972,103 shares during the last quarter. Geode Capital Management LLC grew its stake in Enovix by 6.1% during the 4th quarter. Geode Capital Management LLC now owns 4,413,492 shares of the company’s stock valued at $32,268,000 after purchasing an additional 253,906 shares during the last quarter. Granahan Investment Management LLC grew its stake in Enovix by 17.5% during the 3rd quarter. Granahan Investment Management LLC now owns 1,749,649 shares of the company’s stock valued at $17,444,000 after purchasing an additional 260,085 shares during the last quarter. Finally, Millennium Management LLC grew its stake in Enovix by 1,038.9% during the 3rd quarter. Millennium Management LLC now owns 1,476,879 shares of the company’s stock valued at $14,724,000 after purchasing an additional 1,347,200 shares during the last quarter. Hedge funds and other institutional investors own 50.92% of the company’s stock.

Wall Street Analyst Weigh In

Several analysts have weighed in on ENVX shares. JPMorgan Chase & Co. downgraded Enovix from a “neutral” rating to an “underweight” rating in a research note on Wednesday, May 6th. Bank of America initiated coverage on Enovix in a report on Thursday, March 12th. They issued a “neutral” rating and a $6.00 price objective for the company. TD Cowen reissued a “buy” rating on shares of Enovix in a report on Thursday, May 14th. Benchmark decreased their price objective on Enovix from $25.00 to $15.00 and set a “buy” rating for the company in a report on Thursday, May 14th. Finally, Wall Street Zen raised Enovix from a “strong sell” rating to a “sell” rating in a report on Saturday, May 16th. Seven analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $12.64.

Enovix Stock Performance

ENVX stock opened at $7.28 on Monday. The company has a current ratio of 10.97, a quick ratio of 10.65 and a debt-to-equity ratio of 2.14. Enovix Corporation has a 12-month low of $4.61 and a 12-month high of $16.49. The stock has a market cap of $1.59 billion, a price-to-earnings ratio of -8.77 and a beta of 2.27. The business’s 50-day moving average is $6.50 and its 200 day moving average is $6.78.

Enovix (NASDAQ:ENVX) last announced its earnings results on Wednesday, May 13th. The company reported ($0.14) EPS for the quarter, beating analysts’ consensus estimates of ($0.15) by $0.01. Enovix had a negative return on equity of 64.28% and a negative net margin of 499.64%.The business had revenue of $7.60 million during the quarter, compared to analysts’ expectations of $6.95 million. During the same quarter in the prior year, the firm earned ($0.15) earnings per share. The business’s revenue was up 49.1% compared to the same quarter last year. Enovix has set its Q2 2026 guidance at -0.170–0.130 EPS. On average, sell-side analysts anticipate that Enovix Corporation will post -0.79 EPS for the current fiscal year.

Enovix Profile

Enovix Corporation (NASDAQ: ENVX) develops and manufactures advanced lithium-ion battery cells with a patented three-dimensional silicon-anode architecture. The company’s core focus is on delivering high energy density, improved safety, and longer cycle life compared to conventional graphite-based cells. Enovix’s technology targets a range of applications, including consumer electronics, wearable devices, electric vehicles and stationary energy storage systems.

Founded in 2011 and headquartered in Fremont, California, Enovix has built pilot production capability and is scaling up manufacturing capacity to meet growing demand.